Payment overview · 2025
General Payments
$17.21
1 reported records · 1 companies
Healthcare provider profile · identity verified
Aristides A Martinez, MD
Allopathic & Osteopathic Physicians|Internal Medicine · DELRAY BEACH, FL · NPI 1275518607
Verified facts
What the public records show
CMS Open Payments records show Aristides A Martinez, MD received $17.21 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.21 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.21 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $17.21 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 782 | 242 |
| Atorvastatin Calcium | Atorvastatin Calcium | 587 | 197 |
| Amlodipine Besylate | Amlodipine Besylate | 548 | 168 |
| Levothyroxine Sodium | Levothyroxine Sodium | 480 | 149 |
| Alprazolam | Alprazolam | 422 | 102 |
| Losartan Potassium | Losartan Potassium | 386 | 117 |
| Metformin Hcl | Metformin Hcl | 285 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 283 | 97 |
| Metoprolol Succinate | Metoprolol Succinate | 246 | 75 |
| Lisinopril | Lisinopril | 187 | 64 |
| Omeprazole | Omeprazole | 187 | 59 |
| Sertraline Hcl | Sertraline Hcl | 179 | 59 |
| Zolpidem Tartrate | Zolpidem Tartrate | 167 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 143 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 143 | 50 |
| Simvastatin | Simvastatin | 141 | 37 |
| Trazodone Hcl | Trazodone Hcl | 140 | 37 |
| Ezetimibe | Ezetimibe | 139 | 42 |
| Alendronate Sodium | Alendronate Sodium | 136 | 46 |
| Clonazepam | Clonazepam | 127 | 28 |
| Gabapentin | Gabapentin | 126 | 51 |
| Pravastatin Sodium | Pravastatin Sodium | 113 | 33 |
| Famotidine | Famotidine | 97 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 94 | 30 |
| Atenolol | Atenolol | 93 | 29 |
| Synthroid | Levothyroxine Sodium | 93 | 29 |
| Valsartan | Valsartan | 91 | 29 |
| Allopurinol | Allopurinol | 90 | 31 |
| Furosemide | Furosemide | 87 | 32 |
| Mounjaro | Tirzepatide | 86 | 18 |
| Eliquis | Apixaban | 85 | 25 |
| Carvedilol | Carvedilol | 83 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | 29 |
| Lorazepam | Lorazepam | 80 | 16 |
| Finasteride | Finasteride | 75 | 24 |
| Temazepam | Temazepam | 72 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 22 |
| Potassium Chloride | Potassium Chloride | 69 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 31 |
| Glipizide | Glipizide | 64 | 23 |
| Methylprednisolone | Methylprednisolone | 62 | 61 |
| Jardiance | Empagliflozin | 61 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 25 |
| Tramadol Hcl | Tramadol Hcl | 58 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 57 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | 16 |
| Cefuroxime | Cefuroxime Axetil | 54 | 50 |
| Glimepiride | Glimepiride | 53 | 16 |
| Meloxicam | Meloxicam | 52 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | 16 |
| Mirtazapine | Mirtazapine | 51 | 24 |
| Diazepam | Diazepam | 50 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 48 | 13 |
| Montelukast Sodium | Montelukast Sodium | 47 | 16 |
| Pregabalin | Pregabalin | 47 | 11 |
| Lagevrio (Eua) | Molnupiravir | 46 | 45 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 15 |
| Ozempic | Semaglutide | 44 | 13 |
| Valacyclovir | Valacyclovir Hcl | 44 | 19 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 43 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 43 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 41 | 12 |
| Clonidine Hcl | Clonidine Hcl | 40 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 40 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 40 | 20 |
| Eszopiclone | Eszopiclone | 39 | 16 |
| Xarelto | Rivaroxaban | 39 | 12 |
| Bumetanide | Bumetanide | 38 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 37 | 15 |
| Spironolactone | Spironolactone | 37 | 11 |
| Azithromycin | Azithromycin | 36 | 32 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 35 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 35 | suppressed |
| Memantine Hcl | Memantine Hcl | 35 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Trulicity | Dulaglutide | 32 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 15 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 18 |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | 16 |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | 15 |
| Buspirone Hcl | Buspirone Hcl | 20 | 16 |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Celecoxib | Celecoxib | 19 | 11 |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Irbesartan | Irbesartan | 16 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Methadone Hcl | Methadone Hcl | 15 | suppressed |
| Tadalafil | Tadalafil | 15 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 12 |
| Exelon | Rivastigmine | 13 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.21 · 1 records | Amgen Inc. | KRYSTEXXA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error